Below are the most recent publications written about "Animals" by people in Profiles.
-
Ertekin A, Noronha ST, Darko C, Massi F, Ryder SP. A conserved triple arginine motif in OMA-1 is required for RNA-binding activity and embryo viability. RNA. 2025 Oct 16; 31(11):1575-1588.
-
Schafer DP, Stevens B, Bennett ML, Bennett FC. Role of Microglia in Central Nervous System Development and Plasticity. Cold Spring Harb Perspect Biol. 2025 Oct 01; 17(10).
-
Maloney ME, Potter CT, Chun BD, Liang DA, Montilla RD, Schanbacher CF. Assessment of Needle Point Behavior in Cartilage: Investigating Puncture Force and Suture Retention. Ann Plast Surg. 2025 Oct 01; 95(4):423-426.
-
Chowdhury SR, Parikh CN, Kaur AN, DeMarco KD, Giwa HK, Mishra AK, Murphy KC, Zhou L, Ma B, Ye T, Li J, Liu H, Bai S, Johnson C, Simin K, Pitarresi JR, Zhu LJ, Watson EV, Kelliher MA, Green MR, Fitzgerald KA, Ruscetti M. PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors. Proc Natl Acad Sci U S A. 2025 Sep 30; 122(39):e2514948122.
-
de Souza Silva L, Monks BG, Forconi CS, Crabtree JN, De Paula Tamburro N, Kurt-Jones EA, Gazzinelli RT, Fitzgerald KA, Golenbock DT. Interleukin-10 limits immune-mediated pathology in chronic subclinical plasmodial infection. PLoS Negl Trop Dis. 2025 Sep; 19(9):e0013554.
-
Krieg AM. New insights into the role of IFN-a/? and TLR7/8/9 in cancer immunotherapy and systemic autoimmunity. J Immunother Cancer. 2025 Sep 18; 13(9).
-
Lonfat N, Moreno-Leon L, Punzo C, Khanna H. Update on Gene Therapy Clinical Trials for Eye Diseases. Hum Gene Ther. 2025 Oct; 36(19-20):1287-1300.
-
Xing R, Xu M, Reil D, Destefano A, Cui M, Liu N, Liang J, Xu G, Luo L, Xu M, Zhang F, Tai PWL, Wei Y, Gruntman AM, Flotte TR, Gao G, Wang D. A single amino acid variant in the variable region I of AAV capsid confers liver detargeting. PLoS Pathog. 2025 Sep; 21(9):e1013533.
-
Sun W, Weng W, Shi J, Ma B, D DeMarco K, Gui F, Jin R, Ruscetti M, Jia L, Hu W, Shi Y, Meng X. SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations. Bioconjug Chem. 2025 Oct 15; 36(10):2158-2171.
-
Sarkar S, Chang CI, Jean J, Wu MJ. TCA cycle-derived oncometabolites in cancer and the immune microenvironment. J Biomed Sci. 2025 Sep 10; 32(1):87.